Cargando…
P1609: CAPLACIZUMAB THERAPY IN OLDER PATIENTS (≥60 YEARS) WITH IMMUNE THROMBOTIC THROMBOCYTOPENIC PURPURA (ITTP). RESULTS OF THE SPANISH TTP REGISTRY
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429946/ http://dx.doi.org/10.1097/01.HS9.0000973312.61163.bd |
_version_ | 1785090837970944000 |
---|---|
author | Rubia, Javier DE LA Gómez-Seguí, Inés Cid, Joan Valcárcel, David Goterris, Rosa Zarzoso, Miguel Fernández Mingot-Castellano, María Eva Izquierdo, Cristina Pascual Hernández, Ana Oliva Nieto, Jorge Martínez Idrovo, Laura F. Ávila Coronel, María Liz Paciello Hernández, Luis M. |
author_facet | Rubia, Javier DE LA Gómez-Seguí, Inés Cid, Joan Valcárcel, David Goterris, Rosa Zarzoso, Miguel Fernández Mingot-Castellano, María Eva Izquierdo, Cristina Pascual Hernández, Ana Oliva Nieto, Jorge Martínez Idrovo, Laura F. Ávila Coronel, María Liz Paciello Hernández, Luis M. |
author_sort | Rubia, Javier DE LA |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10429946 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-104299462023-08-17 P1609: CAPLACIZUMAB THERAPY IN OLDER PATIENTS (≥60 YEARS) WITH IMMUNE THROMBOTIC THROMBOCYTOPENIC PURPURA (ITTP). RESULTS OF THE SPANISH TTP REGISTRY Rubia, Javier DE LA Gómez-Seguí, Inés Cid, Joan Valcárcel, David Goterris, Rosa Zarzoso, Miguel Fernández Mingot-Castellano, María Eva Izquierdo, Cristina Pascual Hernández, Ana Oliva Nieto, Jorge Martínez Idrovo, Laura F. Ávila Coronel, María Liz Paciello Hernández, Luis M. Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10429946/ http://dx.doi.org/10.1097/01.HS9.0000973312.61163.bd Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
spellingShingle | Posters Rubia, Javier DE LA Gómez-Seguí, Inés Cid, Joan Valcárcel, David Goterris, Rosa Zarzoso, Miguel Fernández Mingot-Castellano, María Eva Izquierdo, Cristina Pascual Hernández, Ana Oliva Nieto, Jorge Martínez Idrovo, Laura F. Ávila Coronel, María Liz Paciello Hernández, Luis M. P1609: CAPLACIZUMAB THERAPY IN OLDER PATIENTS (≥60 YEARS) WITH IMMUNE THROMBOTIC THROMBOCYTOPENIC PURPURA (ITTP). RESULTS OF THE SPANISH TTP REGISTRY |
title | P1609: CAPLACIZUMAB THERAPY IN OLDER PATIENTS (≥60 YEARS) WITH IMMUNE THROMBOTIC THROMBOCYTOPENIC PURPURA (ITTP). RESULTS OF THE SPANISH TTP REGISTRY |
title_full | P1609: CAPLACIZUMAB THERAPY IN OLDER PATIENTS (≥60 YEARS) WITH IMMUNE THROMBOTIC THROMBOCYTOPENIC PURPURA (ITTP). RESULTS OF THE SPANISH TTP REGISTRY |
title_fullStr | P1609: CAPLACIZUMAB THERAPY IN OLDER PATIENTS (≥60 YEARS) WITH IMMUNE THROMBOTIC THROMBOCYTOPENIC PURPURA (ITTP). RESULTS OF THE SPANISH TTP REGISTRY |
title_full_unstemmed | P1609: CAPLACIZUMAB THERAPY IN OLDER PATIENTS (≥60 YEARS) WITH IMMUNE THROMBOTIC THROMBOCYTOPENIC PURPURA (ITTP). RESULTS OF THE SPANISH TTP REGISTRY |
title_short | P1609: CAPLACIZUMAB THERAPY IN OLDER PATIENTS (≥60 YEARS) WITH IMMUNE THROMBOTIC THROMBOCYTOPENIC PURPURA (ITTP). RESULTS OF THE SPANISH TTP REGISTRY |
title_sort | p1609: caplacizumab therapy in older patients (≥60 years) with immune thrombotic thrombocytopenic purpura (ittp). results of the spanish ttp registry |
topic | Posters |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429946/ http://dx.doi.org/10.1097/01.HS9.0000973312.61163.bd |
work_keys_str_mv | AT rubiajavierdela p1609caplacizumabtherapyinolderpatients60yearswithimmunethromboticthrombocytopenicpurpuraittpresultsofthespanishttpregistry AT gomezseguiines p1609caplacizumabtherapyinolderpatients60yearswithimmunethromboticthrombocytopenicpurpuraittpresultsofthespanishttpregistry AT cidjoan p1609caplacizumabtherapyinolderpatients60yearswithimmunethromboticthrombocytopenicpurpuraittpresultsofthespanishttpregistry AT valcarceldavid p1609caplacizumabtherapyinolderpatients60yearswithimmunethromboticthrombocytopenicpurpuraittpresultsofthespanishttpregistry AT goterrisrosa p1609caplacizumabtherapyinolderpatients60yearswithimmunethromboticthrombocytopenicpurpuraittpresultsofthespanishttpregistry AT zarzosomiguelfernandez p1609caplacizumabtherapyinolderpatients60yearswithimmunethromboticthrombocytopenicpurpuraittpresultsofthespanishttpregistry AT mingotcastellanomariaeva p1609caplacizumabtherapyinolderpatients60yearswithimmunethromboticthrombocytopenicpurpuraittpresultsofthespanishttpregistry AT izquierdocristinapascual p1609caplacizumabtherapyinolderpatients60yearswithimmunethromboticthrombocytopenicpurpuraittpresultsofthespanishttpregistry AT hernandezanaoliva p1609caplacizumabtherapyinolderpatients60yearswithimmunethromboticthrombocytopenicpurpuraittpresultsofthespanishttpregistry AT nietojorgemartinez p1609caplacizumabtherapyinolderpatients60yearswithimmunethromboticthrombocytopenicpurpuraittpresultsofthespanishttpregistry AT idrovolaurafavila p1609caplacizumabtherapyinolderpatients60yearswithimmunethromboticthrombocytopenicpurpuraittpresultsofthespanishttpregistry AT coronelmarializpaciello p1609caplacizumabtherapyinolderpatients60yearswithimmunethromboticthrombocytopenicpurpuraittpresultsofthespanishttpregistry AT hernandezluism p1609caplacizumabtherapyinolderpatients60yearswithimmunethromboticthrombocytopenicpurpuraittpresultsofthespanishttpregistry |